Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer

Published:2015-04-14 Issue:15 Volume:121 Page:2586-2593
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Galsky Matthew D.¹,Pal Sumanta K.²,Chowdhury Simon³,Harshman Lauren C.⁴,Crabb Simon J.⁵,Wong Yu-Ning⁶,Yu Evan Y.⁷,Powles Thomas⁸,Moshier Erin L.⁹,Ladoire Sylvain¹⁰,Hussain Syed A.¹¹,Agarwal Neeraj¹²,Vaishampayan Ulka N.¹³,Recine Federica¹⁴,Berthold Dominik¹⁵,Necchi Andrea¹⁶,Theodore Christine¹⁷,Milowsky Matthew I.¹⁸,Bellmunt Joaquim⁴,Rosenberg Jonathan E.¹⁹,

Affiliation:

1. Department of Hematology and Medical Oncology; Mount Sinai Medical Center; New York New York

2. Department of Medical Oncology and Experimental Therapeutics; City of Hope Comprehensive Cancer Center; Duarte California

3. Department of Urology; Guy's and St. Thomas’ Hospital; London United Kingdom

4. Department of Medical Oncology; Dana-Farber Cancer Institute; Boston Massachusetts

5. Department of Medical Oncology; Southampton General Hospital; Southampton United Kingdom

6. Department of Medical Oncology; Fox Chase Cancer Center; Philadelphia Pennsylvania

7. Division of Oncology; Department of Medicine; Fred Hutchinson Cancer Research Center; Seattle Washington

8. Department of Medical Oncology; Barts Cancer Institute; London United Kingdom

9. Division of Biostatistics; Department of Preventative Medicine; Mount Sinai Medical Center; New York New York

10. Department of Medical Oncology; Georges François Leclerc Center; Dijon France

11. Department of Molecular and Clinical Cancer Medicine; Institute of Translational Medicine, University of Liverpool; Liverpool United Kingdom

12. Department of Medical Oncology; Huntsman Cancer Institute, University of Utah; Salt Lake City Utah

13. Department of Hematology and Oncology; Barbara Ann Karmanos Cancer Center; Detroit Michigan

14. Department of Medical Oncology; Samuel and Barbara Sternberg Cancer Research Foundation; Rome Italy

15. Department of Medical Oncology; University Hospital of Lausanne; Lausanne Switzerland

16. Department of Medical Oncology; Foundation IRCCS National Cancer Institute; Milan Italy

17. Department of Oncology; Hospital Foch; Suresnes France

18. Division of Hematology and Oncology; Department of Medicine; Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina

19. Division of Genitourinary Oncology; Department of Medicine; Memorial Sloan Kettering Cancer Center; New York New York

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29387/fullpdf

Reference34 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer;Bochner;J Clin Oncol,2006

3. The integration of chemotherapy and surgery for bladder cancer;Galsky;J Natl Compr Canc Netw,2005

4. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

5. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial;International Collaboration of Trialists, Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group), European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group;J Clin Oncol,2011

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Neoadjuvant Chemotherapy in Advanced Bladder Cancer;annals of urologic oncology;2024-08-20

2. Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective Studies;Cancer Research and Treatment;2024-07-15

3. Effectiveness of dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin as compared to gemcitabine‐based regimens as neoadjuvant chemotherapy for oncologic outcomes in muscle‐invasive bladder cancer cases—Single‐center study in Japan;International Journal of Urology;2024-05-31

4. Perioperative chemotherapy in bladder cancer: the more cisplatin, the best survival?;World Journal of Urology;2024-03-13

5. The Efficacy of Neoadjuvant Gemcitabine and Cisplatin Chemotherapy for cT3N0M0 Upper Tract Urothelial Carcinoma: The Impact of Tumor Location;UROL J;2024